Since 2020, Drug Topics has partnered with the healthcare business of LexisNexis Risk Solutions to take the pulse of the pharmacy profession. We invite you to take the 2023 survey, providing a look back at 2023 and a snapshot of what 2024 may hold for the pharmacy profession.
Antiseizure Medications Linked to Serious Potential Reaction, FDA Warns
November 30th 2023Levetiracetam and clobazam can cause Drug Reaction with Eosinophilia and Systemic Symptoms, which can start as a rash but progress quickly, potentially resulting in injury to internal organs, hospitalization, and death.
Examining Barriers to Care in Diabetic Retinopathy Screening
November 30th 2023Prior research has shown the association between various socioeconomic variables and lower adherence to diabetic retinopathy screening, but few have elaborated on the patient perspective to understand the reason behind this association.